Friday, September 30, 2011

ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreich's Ataxia

›
EXTON, Pa., Sept. 30, 2011 /PRNewswire via COMTEX/ -- ViroPharma Incorporated (VPHM) today announced the license of worldwide rights from In...

Gene therapies advance towards finish line

›
Nature Reviews Drug Discovery 10, 719-720 (October 2011) | doi:10.1038/nrd3572 Asher Mullard News and Analysis. Over a decade since gene...
Thursday, September 29, 2011

Neural Substrates for the Motivational Regulation of Motor Recovery after Spinal-Cord Injury

›
I am aware that the casuistry of a spinal injury is very distant from the AF, but this paper shows a link between the willingness and recove...
Wednesday, September 28, 2011

Understanding the function of frataxin in eukaryotes

›
PhD Research Project , Medical Research Council, National Institute for Medical Research, PhD Supervisor: Dr A Pastore Application Deadline...

Mitochondrial disorders and the eye

›
Eye and Brain, September 2011 Volume 2011:3 Pages 29 - 47 DOI: http://dx.doi.org/10.2147/EB.S16192 Van Bergen NJ, Chakrabarti R, O’Neill ...
Wednesday, September 21, 2011

1st iissue off EFACTS NEWS

›
The EFACTS (European Friedreich’s Ataxia Consortium for Translational Studies) Consortium will publish the newsletter EFACTS NEWS aimed at c...

Mutation in Fe-S scaffold Isu bypasses frataxin deletion

›
Biochem. J. (2011) Immediate Publication, doi:10.1042/BJ20111637 Heeyong Yoon, Ramesh Golla, Emmanuel Lesuisse, Jayashree Pain, Jason Dona...

Orphan Drugs, Big Pharma

›
Human Gene Therapy. September 2011, 22(9): 1035-1038. doi:10.1089/hum.2011.2515. —Alex Philippidis, Senior News Editor
Sunday, September 18, 2011

Safety and Efficacy of Intravenous Immune Globulin in Treating Friedreich's Ataxia and Spinocerebellar Ataxia

›
Sponsor: University of South Florida Collaborator: Baxter Healthcare Corporation Information provided by (Responsible Party): Theresa Z...

Neuroprotective and metabolic effects of resveratrol: Therapeutic implications for huntington's disease and other neurodegenerative disorders

›
doi:10.1016/j.expneurol.2011.08.014 Giulio Maria Pasinettilow asterisk, a, E-mail The Corresponding Author, Jun Wanga, Philippe Marambauda...